Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Pharmacol Rep ; 75(5): 1166-1176, 2023 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-37730940

RESUMO

BACKGROUND: The aim of the study was to determine the potential of a low-fat diet (LFD) to protect against oxidative and inflammatory damage in the course of asthma and obesity when combined with antioxidants (alpha-lipoic acid-ALA, apocynin-APO) or a probiotic (P) (Lactobacillus casei). METHODS: The experiments were carried out on ten groups of male C57/BL6 mice that were fed standard fat (SFD), low-fat (LFD), or high-fat (HFD) diets. Ovalbumin (OVA, administered subcutaneously and by inhalation) was used to sensitize the animals. IL-1α, IL-10, eotaxin-1, leptin, and TNF-α concentrations were examined in blood, while total glutathione (GSHt), reduced glutathione (GSH), oxidized glutathione (GSSG) and -SH groups were measured in lung homogenates. RESULTS: LFD in combination with the analyzed compounds (APO, P, ALA) significantly decreased the concentration of IL-1α compared to the OVA + HFD group (p < 0.01; p = 0.025; p = 0.002, respectively). Similarly, the treated mice demonstrated lower eotaxin-1 concentrations compared to the HFD group (p < 0.001). Moreover, supplementation of LFD with probiotics significantly increased the concentration of IL-10 vs. controls (p < 0.001) and vs. untreated OVA-sensitized and challenged/obese mice (p < 0.001). Animals administered APO/ALA with LFD displayed a significant decrease in TNF-α concentration compared to OVA + HFD mice (p = 0.013; p = 0.002 respectively). Those treated with ALA displayed significantly improved GSH levels (p = 0.035) compared to OVA + HFD mice. CONCLUSIONS: Supplementation of the tested compounds with LFD appears to have a positive influence on the glutathione redox status of pulmonary tissues and selected inflammatory parameters in mouse blood.

2.
Life Sci ; 234: 116780, 2019 Oct 01.
Artigo em Inglês | MEDLINE | ID: mdl-31430453

RESUMO

Bronchial asthma and obesity are common health problems. Obesity is already responsible for 300,000 deaths per year. AIMS: The aim of the present study was to assess whether apocynin, alpha lipoic acid and probiotic administration in combination with low-fat diet supplementation influences the levels of antioxidant enzymes in the pulmonary tissues of obese asthmatic mice. MAIN METHODS: The study was performed on male C57/BL6 mice divided into 10 groups: (I) control; (II) asthma; (III) obesity; (IV) asthma + obesity; (V) asthma + obesity + apocynin p.o. 15 mg/kg/day for 12 weeks; (VI) asthma + obesity + low-fat diet for 12 weeks; (VII) asthma + obesity + low-fat diet for 12 weeks with apocynin p.o. 15 mg/kg/day; (VIII) asthma + obesity + low-fat diet with probiotics for 12 weeks; (IX) asthma + obesity + low-fat diet for 12 weeks with lipoic acid p.o. 100 mg/kg/day for 12 weeks; (X) asthma + obesity + standard diet with probiotics for 12 weeks. Superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx) and glutathione reductase (GR) activity were examined. The administration of apocynin alone and apocynin in combination with a low-fat diet resulted in a significant increase in SOD values (respectively p < 0.001; p = 0.010). Application of probiotics resulted in a decrease in CAT activity (p = 0.037) and an increase in GPx activity (p < 0.001) compared to obese asthmatic mice. The administration of lipoic acid resulted in an increase in GR activity (p = 0.024 vs. control). KEY FINDINGS: Supplementation containing apocynin, lipoic acid and probiotics has a positive influence on the antioxidant capacity of the pulmonary tissues of obese asthmatic mice. SIGNIFICANCE: These results may contribute to the development of new therapeutic approaches.


Assuntos
Acetofenonas/uso terapêutico , Antioxidantes/uso terapêutico , Asma/tratamento farmacológico , Obesidade/tratamento farmacológico , Probióticos/uso terapêutico , Ácido Tióctico/uso terapêutico , Animais , Asma/complicações , Asma/metabolismo , Catalase/análise , Catalase/metabolismo , Glutationa Peroxidase/análise , Glutationa Peroxidase/metabolismo , Pulmão/efeitos dos fármacos , Pulmão/metabolismo , Masculino , Camundongos Endogâmicos C57BL , Camundongos Obesos , Obesidade/complicações , Obesidade/metabolismo , Estresse Oxidativo/efeitos dos fármacos , Superóxido Dismutase/análise , Superóxido Dismutase/metabolismo
3.
Oxid Med Cell Longev ; 2016: 1340903, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27066188

RESUMO

The aim of the present study was to assess whether probiotic bacteria Lactobacillus casei (4 × 10(8) CFU) influences the antioxidant properties of human plasma when combined with prebiotic Inulin (400 mg). Experiments were carried out on healthy volunteers (n = 32). Volunteers were divided according to sex (16 male and 16 female) and randomly assigned to synbiotic and control groups. Blood samples were collected before synbiotic supplementation and after 7 weeks, at the end of the study. Catalase (CAT), superoxide dismutase (SOD), glutathione peroxidase (GPx) activity, and the ferric reducing ability of plasma (FRAP) in human plasma were examined. The administration of synbiotics containing L. casei plus Inulin resulted in a significant increase in FRAP values (p = 0.00008) and CAT activity (p = 0.02) and an insignificant increase in SOD and GPx activity compared to controls. Synbiotics containing L. casei (4 × 10(8) CFU) with prebiotic Inulin (400 mg) may have a positive influence on human plasma antioxidant capacity and the activity of selected antioxidant enzymes.


Assuntos
Antioxidantes/análise , Suplementos Nutricionais , Inulina/farmacologia , Lacticaseibacillus casei/fisiologia , Probióticos , Adulto , Antioxidantes/química , Catalase/sangue , Catalase/metabolismo , Feminino , Compostos Férricos/química , Glutationa Peroxidase/sangue , Glutationa Peroxidase/metabolismo , Humanos , Masculino , Prebióticos , Superóxido Dismutase/sangue , Superóxido Dismutase/metabolismo , Simbióticos , Regulação para Cima
4.
Pharmacol Rep ; 63(4): 849-58, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-22001972

RESUMO

α-Lipoic acid (LA; 5-(1,2-dithiolan-3-yl)pentanoic acid) was originally isolated from bovine liver by Reed et al. in 1951. LA was once considered a vitamin. Subsequently, it was found that LA is not a vitamin and is synthesized by plants and animals. LA is covalently bound to the ε-amino group of lysine residues and functions as a cofactor for mitochondrial enzymes by catalyzing the oxidative decarboxylation of pyruvate, α-ketoglutarate and branched-chain α-keto acids. LA and its reduced form - dihydrolipoic acid (DHLA), meet all the criteria for an ideal antioxidant because they can easily quench radicals, can chelate metals, have an amphiphlic character and they do not exhibit any serious side effects. They interact with other antioxidants and can regenerate them. For this reason, LA is called an antioxidant of antioxidants. LA has an influence on the second messenger nuclear factor κB (NF-κB) and attenuates the release of free radicals and cytotoxic cytokines. The therapeutic action of LA is based on its antioxidant properties. Current studies support its use in the ancillary treatment of many diseases, such as diabetes, cardiovascular, neurodegenerative, autoimmune diseases, cancer and AIDS. This review was undertaken to gather the most recent information regarding the therapeutic properties of LA and its possible utility in disease treatment.


Assuntos
Antioxidantes/uso terapêutico , Suplementos Nutricionais , Ácido Tióctico/farmacologia , Animais , Antioxidantes/metabolismo , Antioxidantes/farmacologia , Bovinos , Citocinas/metabolismo , Radicais Livres/metabolismo , Humanos , Ácido Tióctico/análogos & derivados , Ácido Tióctico/metabolismo , Ácido Tióctico/uso terapêutico
5.
Pol Merkur Lekarski ; 29(174): 361-4, 2010 Dec.
Artigo em Polonês | MEDLINE | ID: mdl-21298985

RESUMO

UNLABELLED: Free radicals are atoms, molecules or their fragments, which excess leads to the development of the oxidative stress, which is caused of many neoplasmic, neurodegenerative, inflammatory diseases and aging the organism. The main of exogenous sources of free radicals are among others: industrial pollution, tobacco smoke, ionizing radiation, ultrasound and magnetic field. The low magnetic field is applied in the physician therapy. The aim of this study was to evaluate the influence of low magnetic field on the parameters of oxidative stress in rat's muscles. MATERIALS AND METHODS: Thirty male rats, weight of 280-300 g were randomly divided into three experimental groups: control I and treatment II and III (ELFMF-exposed), each containing seven animals. Animals in treat group II were exposed to 40 Hz, 7 mT for 0.5 h/day for 14 days (this kind of the ELFMF is mostly use in magnetotherapy) while, group III was exposed to 40 Hz, 7 mT for 1 h/day for 14 days. Control rats were in separate room without exposing to ELFMF. Immediately after the last exposure, the part of muscles was taken under pentobarbital anaesthesia. The effects of exposure to ELFMF on oxidative states were assessed on the measurements of concentration of -SH group, H2O2, and the concentration of proteins in muscles homogenates. RESULTS: Exposure to ELFMF: 40 Hz, 7 mT, 30 and 60 min/day used for 2 weeks caused significant increase in -SH group concentration and decrease of the protein concentration in the muscles homogenates. CONCLUSION: Low magnetic field used in magnetotherapy causes the significant changes of the generating the reactive forms of oxygen in the muscles which depend on the parameters of low magnetic field.


Assuntos
Campos Eletromagnéticos , Magnetoterapia , Músculo Esquelético/metabolismo , Músculo Esquelético/efeitos da radiação , Estresse Oxidativo/efeitos da radiação , Animais , Feminino , Masculino , Distribuição Aleatória , Ratos , Ratos Sprague-Dawley
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA